MADRIGAL PHARMACEUTICALS, INC. Warrants and Rights Outstanding
MADRIGAL PHARMACEUTICALS, INC. (MDGL) had Warrants and Rights Outstanding of $900.00 thousand as of 2023-09-30, per its 10-K filed 2026-02-19.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2026-02-19
- 2023-09-30: Warrants and Rights Outstanding $900.00K.
- 2022-05-31: Warrants and Rights Outstanding $600.00K.
- 2022-05-01: Warrants and Rights Outstanding $600.00K.
| Period end | Warrants and Rights Outstanding |
|---|---|
| 2023-09-30 | $900.00K 10-K · filed 2026-02-19 |
| 2022-05-31 | $600.00K 10-K · filed 2026-02-19 |
| 2022-05-01 | $600.00K 10-K · filed 2025-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |